ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.460
+0.040 (1.65%)
Aug 3, 2026, 11:38 AM CET
EPA:ABLD Revenue
In the year 2025, ABL Diagnostics Société anonyme had annual revenue of 8.35M EUR with 30.03% growth. ABL Diagnostics Société anonyme had revenue of 4.94M in the half year ending December 31, 2025, with 38.76% growth.
Revenue
8.35M
Revenue Growth
+30.03%
P/S Ratio
4.88
Revenue / Employee
362.08K
Employees
22
Market Cap
38.89M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.35M | 1.93M | 30.03% |
| Dec 31, 2024 | 6.42M | -1.73M | -21.22% |
| Dec 31, 2023 | 8.15M | -2.34M | -22.31% |
| Dec 31, 2022 | 10.49M | 10.09M | 2,521.73% |
| Dec 31, 2021 | 400.12K | 282.62K | 240.51% |
| Dec 31, 2020 | 117.51K | 11.18K | 10.52% |
| Dec 31, 2019 | 106.33K | -8.29M | -98.73% |
| Dec 31, 2018 | 8.40M | 7.31M | 670.20% |
| Dec 31, 2017 | 1.09M | 518.51K | 90.63% |
| Dec 31, 2016 | 572.15K | 205.76K | 56.16% |
| Dec 31, 2015 | 366.39K | -917.59K | -71.46% |
| Dec 31, 2014 | 1.28M | 381.18K | 42.22% |
| Dec 31, 2013 | 902.80K | 573.45K | 174.12% |
| Dec 31, 2012 | 329.35K | 94.06K | 39.97% |
| Dec 31, 2011 | 235.29K | -9.75K | -3.98% |
| Dec 31, 2010 | 245.05K | -19.65K | -7.42% |
| Dec 31, 2009 | 264.70K | -80.48K | -23.32% |
| Dec 31, 2008 | 345.18K | 28.88K | 9.13% |
| Dec 31, 2007 | 316.31K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 47.35B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Novacyt | 22.96M |
| Klea Holding | 22.17M |
| Nicox | 16.77M |
| Fermentalg | 13.38M |